VEGFA and amyotrophic lateral sclerosis: Given these preclinical results, a phase I–II clinical trial was carried out to evaluate safety and tolerability of intracerebroventricular VEGF infusion in patients with ALS (unpublished results, clinicaltrial.gov: NCT00800501).